A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation

AIMS: The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime...

Descripción completa

Detalles Bibliográficos
Autores principales: LaHaye, Stephen Andrew, Gibbens, Sabra Lynn, Ball, David Gerald Andrew, Day, Andrew George, Olesen, Jonas Bjerring, Skanes, Allan Cameron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432235/
https://www.ncbi.nlm.nih.gov/pubmed/22752615
http://dx.doi.org/10.1093/eurheartj/ehs167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432235/
https://www.ncbi.nlm.nih.gov/pubmed/22752615
http://dx.doi.org/10.1093/eurheartj/ehs167

Ejemplares similares